(89 days)
No
The description focuses on the mechanical and physical components of a blood reservoir system for cardiopulmonary bypass, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes
The device is used in extracorporeal circulation during cardiopulmonary bypass surgery, and is also used for the collection and autotransfusion of shed blood, which are therapeutic medical procedures.
No
This device is a reservoir and filter system used during cardiopulmonary bypass surgery to manage blood, not to diagnose a medical condition.
No
The device description clearly details a physical, hardware-based medical device (reservoirs, filters, ports, housing) used in cardiopulmonary bypass surgery. There is no mention of software as the primary or sole component.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for use in infants undergoing cardiopulmonary bypass surgery requiring extracorporeal circulation. It functions as a reservoir for blood during this process and for autotransfusion of shed blood. This is a therapeutic and supportive function during surgery, not a diagnostic one.
- Device Description: The description details the physical components and how the device handles blood flow, filtering, and collection. It describes a mechanical system for managing blood during surgery.
- Lack of Diagnostic Function: There is no mention of the device being used to analyze blood, detect markers, or provide any information for diagnosing a condition. Its purpose is to manage blood flow and volume during a surgical procedure.
IVD devices are used to examine specimens (like blood, urine, or tissue) from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device does not perform such a function.
N/A
Intended Use / Indications for Use
The Dideco D920, Lilliput I twin reservoir is intended for use in infants who undergo cardiopulmonary bypass surgery requiring extracorporeal circulation for whom a low circuit priming volume is required. The venous reservoir with cardiotomy filter is intended for use as a storage reservoir (gravity or vacuumassisted) for venous return blood and as a filtered reservoir for cardiac suction during ECC. The cardiotomy reservoir has the same intended use as the venous reservoir, as a filtered reservoir for cardiac suction blood in a bypass extracorporeal circuit, but does not have a venous return. Following intraoperative use, the reservoirs are used for the collection and autotransfusion of shed blood.
Product codes (comma separated list FDA assigned to the subject device)
DTN, DTP
Device Description
The D 920 serves as a collection reservoir for venous blood recovered by intracardiac sucker and ventricular vent devices. The D 920 device can also be attached to an oxygenator, previously cleared by the Agency for the same patient population, in order to collect blood during normal operations, assuring the proper oxygenation capability of the device is currently being developed in an open system configuration which includes the Dideco D901 Lilliput oxygenator, cleared by the Agency on March 15th 1996 (K953835).
The hard-shell cardiotomy/venous reservoirs are comprised of a rigid polycarbonate housing with an internal support; in which a filtering system is placed around the support. The D 920 has two distinct (upper and lower) sections connected by an overflow system. The upper section contains a defoamer sponge and screen filter which are designed to remove microaggregates and microemboli from cardiotomy suction and vent blood. The devices are available with a 30 micron filter. The venous return blood enters the lower section and passes through a defoamer sponge. Only the lower section is contained within a polyester outer screen.
The D 920 has four cardiotomy suction/vent inlet ports which accommodate both 1/4 and 3/16" inner diameter tubing. Three priming ports are positioned on the top of the reservoir: 3 x luer lock (filtered), 1 x luer lock (unfiltered) and 1 x 1/4-3/16". Fluid added through the one outer priming port bypasses the integral cardiotomy section. Fluids added through the three inner luer and 1/4-3/16" ports flow through the defoamer and filter elements in the cardiotomy section. Venous blood enters through the 1/4-3/16" inlet port at the bottom of the unit. The D 920 has a 1/4-3/16" blood outlet port at the bottom of the unit. The 1/4" gas outlet port is located at the top of the unit. Both devices are supported by a holder.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Infants
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Dideco D 920 has successfully completed the full range of biocompatability testing as specified in ISO 10993-1:1992 and FDA May 1, 1995 Memorandum on the use of the ISO 10993 standard for Biocompatibility Testing. Dideco has also successfully performed in vitro performance testing on the D 920 based on the ISO 7199 international standard.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)
Not Found
§ 870.4230 Cardiopulmonary bypass defoamer.
(a)
Identification. A cardiopulmonary bypass defoamer is a device used in conjunction with an oxygenator during cardiopulmonary bypass surgery to remove gas bubbles from the blood.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Extracorporeal Blood Circuit Defoamer 510(k) Submissions.”
0
510(k) Safety and Effectiveness Summary
1. Submitted by:
Barry Sall Senior Regulatory Consultant PAREXEL International Corporation Waltham, MA, USA
2. Contact Person:
Luigi Vecchi Regulatory Affairs Manager Dideco, S.p.A. via Statale 12 Nord, 86 P.O. Box 87 41037 Mirandola (MODENA) Italy
Telephone number: 01139 0535 29811
3 Date of Preparation:
December 2, 1998
Name and Address of Owner/Operator and Manufacturer 4
Dideco, S.p.A. via Statale 12 Nord, 86 P.O. Box 87 41037 Mirandola (MODENA) Italy
5 Product Name
Trade Name: D 920, Lilliput 1 twin reservoir
Common Name: Infant-newborn Venous Cardiotomy Reservoir
6. Predicate Devices
1) VENOMIDICARD/MIDICARD D752/D762 manufactured by:
Dideco S.p.A.. Via Statale 12 Nord, 86 41037 Mirandola (MO) ITALY
K941215, cleared on May 5, 1995
1
- MICRO SAFE manufactured by:
Polystan AJS Walgerholm 8 3500 Vaerlose DENMARK
K953976, cleared on February 4, 1997
7. Claim of Substantial Equivalence
The D 920 is an infant/newborn hard-shell venous reservoir, like the predicate devices. The basic function of all hardshell reservoirs is the same. They store the blood coming from the surgical theater, draw it from the venous reservoir and push it through an oxygenator via an external pump. The operating principles and control mechanisms are exactly the same for the D 920 and the predicate devices.
As both the Venomidicard and the D 920 are manufactured by Dideco, they share the same incoming raw materials inspections, manufacturing in process controls; in addition the D 920 utilizes the same material type and a similar blood flow path as the Venomidicard and the filtration sequence is the same for D 920 and Venomidicard.
The indications for use are the same for both D 920, Micro safe and Venomidicard: all devices are intended for the infant population who undergo cardiopulmonary bypass surgery requiring extracorporeal circulation.
All predicate devices have a bayonet/YSI 400 compatible temperature probe.
| Parameters | VENOMIDICARD/
MIDICARD | MICRO-SAFE | D 920 |
|------------------------------------------|---------------------------|----------------|----------------|
| Manufacturer | Dideco S.p.A. | Polystan A/V. | Dideco S.p.A. |
| Method of sterilization | Ethylene Oxyde | Ethylene Oxyde | Ethylene oxide |
| Maximum blood flow rate | 4 LPM | 0.8 LPM | 1.5 LPM |
| Recommended operating
blood flow rate | 4000 ml/min | 800 ml/min | 800 ml/min |
| Filtering pore size | 20 micron | 40 micron | 30 micron |
Substantial Equivalence Comparison Chart: Performance Characteristics
2
Substantial Equivalence Comparison Chart: General features
| Parameters | VENOMIDICARD/
MIDICARD | MICRO-SAFE | D 920 |
|----------------------------|----------------------------|---------------------------|----------------------------|
| Connections: | | | |
| Venous return | 3/16" | 3/16" - 1/4" | 3/16" - 1/4" |
| Venous outlet | 3/8" | 3/16" - 1/4" | 3/16" - 1/4" |
| Cardiotomy inlet | 3/16" - 1/4" | 3/16" - 1/4" | 3/16" - 1/4" |
| Reservoir venous inlet | 3/8" | 1/4" | 1/4" |
| Filter materials: | | | |
| Cardiotomy filter | polyester 20 microns | polyester 40 microns | polyester 30 microns |
| Reservoir filter | polyurethane | polyurethane | polyurethane |
| Screen filter | polyester 120 microns | polyester 175 microns | polyester 120 microns |
| Available
configuration | Card. /venous
reservoir | Venous reservoir | Card. /venous
reservoir |
| Housing: | | | |
| type | rigid hardshell | rigid hardshell | rigid hardshell |
| material | polycarbonate | polycarbonate | polycarbonate |
| max. volume | 2000 ml | 400 ml | 700 ml |
| Packaging: | | | |
| type | Single/multi unit box | single/multi unit box | single/multi unit box |
| material | Tyvek pouch/carton
box | Tyvek pouch/carton
box | Tyvek pouch/carton
box |
| Patient population | Children | Infants | Infants |
8. Device Description
The D 920 serves as a collection reservoir for venous blood recovered by intracardiac sucker and ventricular vent devices. The D 920 device can also be attached to an oxygenator, previously cleared by the Agency for the same patient population, in order to collect blood during normal operations, assuring the proper oxygenation capability of the device is currently being developed in an open system configuration which includes the Dideco D901 Lilliput oxygenator, cleared by the Agency on March 15th 1996 (K953835).
The hard-shell cardiotomy/venous reservoirs are comprised of a rigid polycarbonate housing with an internal support; in which a filtering system is placed around the support. The D 920 has two distinct (upper and lower) sections connected by an overflow system. The upper section contains a defoamer sponge and screen filter which are designed to remove microaggregates and microemboli from cardiotomy suction and vent blood. The devices are available with a 30 micron filter. The venous return blood enters the lower section and passes through a defoamer sponge. Only the lower section is contained within a polyester outer screen.
The D 920 has four cardiotomy suction/vent inlet ports which accommodate both 1/4 and 3/16" inner diameter tubing. Three priming ports are positioned on the top of the reservoir: 3 x luer lock (filtered), 1 x luer lock (unfiltered) and 1 x 1/4-3/16". Fluid added through the one outer priming port bypasses the integral cardiotomy section. Fluids added through the three inner luer and 1/4-3/16" ports flow through the defoamer and filter elements in the cardiotomy section. Venous blood enters through the 1/4-3/16" inlet port at the bottom of the unit. The D 920 has a 1/4-3/16" blood outlet port at the bottom of the unit. The 1/4" gas outlet port is located at the top of the unit. Both devices are supported by a holder.
3
9. Intended Use
The Dideco D 920 is intended for use in infants who undergo cardiopulmonary bypass surgery requiring extracorporeal circulation (ECC) for whom a low circuit priming volume is required. The venous reservoir with cardiotomy filter is intended for use as a storage reservoir (gravity or vacuumassisted) for venous return blood and as a filtered reservoir for cardiac suction during ECC. The cardiotomy reservoir has the same intended use as the venous reservoir above mentioned as a filtered reservoir for cardiac suction blood in a bypass extracorporeal circuit, but does not have a venous return.
Following intraoperative use, the reservoirs are used for the collection and autotransfusion of shed blood.
10. Summary of Nonclinical Data
The Dideco D 920 has successfully completed the full range of biocompatability testing as specified in ISO 10993-1:1992 and FDA May 1, 1995 Memorandum on the use of the ISO 10993 standard for Biocompatibility Testing. Dideco has also successfully performed in vitro performance testing on the D 920 based on the ISO 7199 international standard.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/2 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the top half of the circle. Inside the circle is a stylized image of an eagle with three heads.
MAR - 2 1999
Dideco, S.P.A. c/o Mr. Barry Sall Senior Regulatory Consultant Parexel International Corporation 1601 Trapelo Road Waltham, MA 02154
Re : K984322 Dideco D920, Lilliput 1 Twin Reservoir Regulatory Class: II (Two) and III (Three) Product Code: DTN and DTP Dated: December 2, 1998 Received: December 3, 1998
Dear Mr. Sall:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to A substantially equivalent determination assumes compliance with 895. the Current Good Manufacturing Practice requirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
5
Page 2 - Mr. Barry Sall
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in_vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahon
Thomas J. Callaman, Ph.D. Director Division of Cardiovascular, Respiratory and Neuroloqical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
k 984322 510(k) Number (if known):
Device Name: Dideco D920, Lilliput 1 twin reservoir
Indications for Use:
The Dideco D920, Lilliput I twin reservoir is intended for use in infants who undergo cardiopulmonary bypass surgery requiring extracorporeal circulation for whom a low circuit priming volume is required. The venous reservoir with cardiotomy filter is intended for use as a storage reservoir (gravity or vacuumassisted) for venous return blood and as a filtered reservoir for cardiac suction during ECC. The cardiotomy reservoir has the same intended use as the venous reservoir, as a filtered reservoir for cardiac suction blood in a bypass extracorporeal circuit, but does not have a venous return. Following intraoperative use, the reservoirs are used for the collection and autotransfusion of shed blood.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Satie & Compule
(Division Sign-Off)
Division of Cardiovascular, Respiratory,
and Neurological Devices
510(k) Number K984322
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional format 1-2-96)